Yangjing Zhao

1.6k total citations
40 papers, 1.1k citations indexed

About

Yangjing Zhao is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yangjing Zhao has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Immunology. Recurrent topics in Yangjing Zhao's work include Cancer-related molecular mechanisms research (7 papers), Immune Cell Function and Interaction (6 papers) and MicroRNA in disease regulation (5 papers). Yangjing Zhao is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Immune Cell Function and Interaction (6 papers) and MicroRNA in disease regulation (5 papers). Yangjing Zhao collaborates with scholars based in China, United States and Spain. Yangjing Zhao's co-authors include Qixiang Shao, Guangyong Peng, Hui Wang, Fusheng Si, Jing‐dong Zhou, Xia Liu, Wenli Lin, Aiqin Gao, Daniel F. Hoft and Lan Huang and has published in prestigious journals such as Oncogene, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Yangjing Zhao

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yangjing Zhao China	15	456	442	286	272	125	40	1.1k
Qing Xi China	17	546 1.2×	311 0.7×	321 1.1×	217 0.8×	117 0.9×	33	1.0k
Enyu Rao United States	13	507 1.1×	674 1.5×	223 0.8×	340 1.3×	92 0.7×	18	1.1k
Halil‐Ibrahim Aksoylar United States	12	582 1.3×	781 1.8×	181 0.6×	301 1.1×	145 1.2×	19	1.3k
Matthew R. Farren United States	19	396 0.9×	482 1.1×	195 0.7×	625 2.3×	74 0.6×	34	1.3k
Zhigang Chen China	21	590 1.3×	233 0.5×	436 1.5×	338 1.2×	92 0.7×	74	1.4k
Shengping Huang United States	17	585 1.3×	255 0.6×	218 0.8×	262 1.0×	133 1.1×	31	1.2k
Haimeng Yan China	12	541 1.2×	314 0.7×	230 0.8×	183 0.7×	92 0.7×	25	944
Hsiao‐Chi Tsai Taiwan	19	564 1.2×	187 0.4×	246 0.9×	275 1.0×	96 0.8×	31	1.0k
Federica Raggi Italy	14	256 0.6×	716 1.6×	222 0.8×	265 1.0×	71 0.6×	24	1.1k

Countries citing papers authored by Yangjing Zhao

Since Specialization

Citations

This map shows the geographic impact of Yangjing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangjing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangjing Zhao more than expected).

Fields of papers citing papers by Yangjing Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangjing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangjing Zhao. The network helps show where Yangjing Zhao may publish in the future.

Co-authorship network of co-authors of Yangjing Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yangjing Zhao. A scholar is included among the top collaborators of Yangjing Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangjing Zhao. Yangjing Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yun, Ting‐juan Zhang, Zi‐jun Xu, et al.. (2025). Overexpression and oncogenic role of RIPK3 in acute myeloid leukemia associated with specific subtypes and treatment outcome. BMC Cancer. 25(1). 253–253.

Xie, Fei, Ting‐juan Zhang, Xinlong Zhang, et al.. (2025). Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia. BMC Cancer. 25(1). 215–215. 2 indexed citations

Zhao, Yangjing, Jiaxin Xu, Yue You, et al.. (2025). ID1 in hematopoiesis and hematologic disorders: novel potentials of a classic differentiation regulator. Cellular & Molecular Biology Letters. 30(1). 124–124.

Chen, Jia, et al.. (2025). Dual antibody-guided drug delivery systems using MOF-PQDs nanocomposites for precise tumor diagnosis and combination therapy. Chemical Engineering Journal. 505. 159275–159275. 9 indexed citations

Ming, Wuyi, Yangjing Zhao, Chen Cao, et al.. (2023). Numerical and experimental study on EDM drilling of Ti-Cu-Zr metallic glass considering energy efficiency. The International Journal of Advanced Manufacturing Technology. 128(9-10). 3949–3968. 2 indexed citations

Zhao, Yangjing, et al.. (2023). Megamitochondria plasticity: Function transition from adaption to disease. Mitochondrion. 71. 64–75. 9 indexed citations

Zhao, Yangjing, Weili Cai, Hua Ye, Xiaochen Yang, & Jing‐dong Zhou. (2022). The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid Malignancies. Cancers. 14(18). 4406–4406. 16 indexed citations

Zhao, Yangjing, Hui Wang, Jing‐dong Zhou, & Qixiang Shao. (2022). Glutathione Peroxidase GPX1 and Its Dichotomous Roles in Cancer. Cancers. 14(10). 2560–2560. 68 indexed citations

Ye, Qing, Chunyi Zhao, Qian Wu, et al.. (2022). A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma. Disease Markers. 2022. 1–11. 4 indexed citations

10.

Zhou, Jing‐dong, Yangjing Zhao, Yu Gu, et al.. (2022). DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis. Cellular & Molecular Biology Letters. 27(1). 59–59. 4 indexed citations

11.

Zhao, Qi, Yun Wang, Di Yu, et al.. (2022). Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation. BMC Cancer. 22(1). 1229–1229. 2 indexed citations

12.

Liu, Xia, Celine L. Hartman, Lingyun Li, et al.. (2021). Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Science Translational Medicine. 13(587). 200 indexed citations

13.

Wu, Haojie, Xiaohan Li, Chen Zhou, et al.. (2021). Circulating mature dendritic cells homing to the thymus promote thymic epithelial cells involution via the Jagged1/Notch3 axis. Cell Death Discovery. 7(1). 225–225. 5 indexed citations

14.

Zhao, Yangjing, et al.. (2021). Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape. Frontiers in Immunology. 12. 641937–641937. 9 indexed citations

15.

Jiang, Feng, et al.. (2021). PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers. Cancers. 13(23). 6101–6101. 3 indexed citations

16.

Liu, Xia, Lingyun Li, Fusheng Si, et al.. (2021). NK and NKT cells have distinct properties and functions in cancer. Oncogene. 40(27). 4521–4537. 52 indexed citations

17.

Gao, Shujun, et al.. (2021). Decidual Natural Killer Cells: A Good Nanny at the Maternal-Fetal Interface During Early Pregnancy. Frontiers in Immunology. 12. 663660–663660. 52 indexed citations

18.

Zhao, Yangjing, Yanhui Chen, Ying Hu, et al.. (2018). Genomic alterations across six hepatocellular carcinoma cell lines by panel-based sequencing. Translational Cancer Research. 7(2). 231–239. 5 indexed citations

19.

Liao, Weijia, Yangjing Zhao, Yanhui Chen, et al.. (2017). IL-10 and IL-10RB gene polymorphisms are correlated with hepatitis B-related hepatocellular carcinoma in the Chinese Han population. Translational Cancer Research. 6(2). 432–440. 2 indexed citations

20.

Zhao, Yangjing, Xingwang Xie, Weijia Liao, et al.. (2016). The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma. Oncology Reports. 37(1). 289–296. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact